Compare GH & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | HTHT |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 14.8B |
| IPO Year | 2018 | 2010 |
| Metric | GH | HTHT |
|---|---|---|
| Price | $101.85 | $51.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 21 | 2 |
| Target Price | ★ $102.81 | $47.00 |
| AVG Volume (30 Days) | ★ 2.1M | 1.4M |
| Earning Date | 02-19-2026 | 03-19-2026 |
| Dividend Yield | N/A | ★ 3.52% |
| EPS Growth | N/A | ★ 7.24 |
| EPS | N/A | ★ 1.76 |
| Revenue | $902,569,000.00 | ★ $3,484,239,807.00 |
| Revenue This Year | $35.23 | $7.12 |
| Revenue Next Year | $27.38 | $6.64 |
| P/E Ratio | ★ N/A | $28.74 |
| Revenue Growth | ★ 30.38 | 5.77 |
| 52 Week Low | $34.88 | $30.20 |
| 52 Week High | $120.74 | $51.46 |
| Indicator | GH | HTHT |
|---|---|---|
| Relative Strength Index (RSI) | 38.60 | 55.64 |
| Support Level | $97.88 | $46.84 |
| Resistance Level | $118.00 | $50.89 |
| Average True Range (ATR) | 5.67 | 1.34 |
| MACD | -1.94 | -0.06 |
| Stochastic Oscillator | 11.61 | 76.11 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, managed, and franchised models. The company has two operating segments: legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.